TWiV 880: COVID-19 clinical update #107 with Dr. Daniel Griffin
This Week in Virology
00:00
Immuno Bridging
The vaccine efficacy for preventing symptomatic infection in children six months to two years was forty three point seven. And then vaxin efficacy was 37 point five in the two to under six years age group. They comment that the majority cases were mild, no severe. Covet 19, no hospitalizations, no deaths. Wasn't our primary andpoint, but youre pria going to want to know.
Transcript
Play full episode
